IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Contra Zynerba Pharmac Com

CUSIP: 989CVR022 | 4 institutional holders

Quarters

Q3 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Ascentis Independent Advisors23
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Ascentis Independent Advisors
23$00.0%GrowthLowDallas, TX2026-11-03